XYNTHA SOLOFUSE
Google image searchProduct monograph
Active ingredient
moroctocog alfa, 3000 UNIT/SYR
DIN: 02374099
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE, DUAL-CHAMBER SYRINGE, PREFILLED WITH XYNTHA AND 4ML DILUENT
Schedule: Schedule D
Company: PFIZER CANADA ULC
Date: 08-MAY-2012
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BD — Blood coagulation factors (ATC, ATC/DDD)
- B02BD02 — COAGULATION FACTOR VIII (ATC/DDD)
Reference brand drug: Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Nuwiq, Obizur, Xyntha, Zonovate
Pharmaceutical standard: MFR
